Motus GI (MOTS:NASDAQ) Investor Relations Material

Overview

Motus GI Holdings, Inc., a US-based medical technology company, has reportedly developed a groundbreaking medical device that promises to revolutionize the gastrointestinal (GI) tract cleansing process during colonoscopy and upper GI endoscopy procedures. The device, known as the Pure-Vu System, allows for the effective cleansing of a poorly prepared GI tract by improving visualization and removing debris from the colon. The company, formerly known as Eight-Ten Merger Corp., rebranded as Motus GI Holdings, Inc. in November 2016. With its headquarters in Fort Lauderdale, Florida, Motus GI Holdings, Inc. was founded in 2008 and continues to make significant strides in the medical technology industry.

Frequently Asked Questions

What is Motus GI's ticker?

Motus GI's ticker is MOTS

What exchange is Motus GI traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Motus GI's headquarters?

They are based in Fort Lauderdale, Florida

How many employees does Motus GI have?

There are 11-50 employees working at Motus GI

What is Motus GI's website?

It is motusgi.com

What type of sector is Motus GI?

Motus GI is in the Healthcare sector

What type of industry is Motus GI?

Motus GI is in the Biotechnology industry

Who are Motus GI's peers and competitors?

The following five companies are Motus GI's industry peers:

- CTI BioPharma

- Moderna

- Mirion

- Selecta Biosciences

- Intelgenx Technologies Corp